Ironwood Pharmaceuticals (IRWD) Raw Materials (2016 - 2019)

Ironwood Pharmaceuticals (IRWD) posted Raw Materials of $65000.0 for Q4 2019, down 94.27% sequentially from $1.1 million in Q3 2019.

Ironwood Pharmaceuticals (IRWD) Raw Materials (2016 - 2019) Analysis & Trends

Ironwood Pharmaceuticals has reported Raw Materials for 4 years, with the latest figure at $65000.0 in Q4 2019.

Quarterly Raw Materials changed N/A year-over-year to $65000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $65000.0 (changed N/A YoY) and the FY2019 annual result came in at $65000.0, changed N/A from the prior year.
Raw Materials eased to $65000.0 in Q4 2019 per IRWD's latest filing, from $1.1 million in the prior quarter.
Over five years, Raw Materials peaked at $1.5 million in Q1 2017 and troughed at $65000.0 in Q4 2019.
A 4-year average of $800750.0 and a median of $801500.0 in 2016 frame the typical range for Raw Materials.
The sharpest annual moves came in 2018 and 2019: Raw Materials tumbled 79.64% in 2018, then surged 378.9% in 2019.
Over 4 years, Raw Materials stood at $1.0 million in 2016, then jumped by 49.8% to $1.5 million in 2017, then sank by 79.64% to $308000.0 in 2018, then plunged by 78.9% to $65000.0 in 2019.
According to Business Quant data, Raw Materials over the past three periods registered $65000.0, $1.1 million, and $1.5 million for Q4 2019, Q3 2019, and Q2 2019 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-
10	Ironwood Pharmaceuticals	669.95 Mn	590.82 Mn	-

Download Data